Phase I trial of ImmTher, a new liposome-incorporated lipophilic disaccharide tripeptide.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/9EA59069.svg?ark=w1%2F20260515%2F9EA59069)](https://nobleid.org/work/w1/20260515/9EA59069)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors